Drug Trial Radar · NCT07210515
Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)
Last checked: Nov 19, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
270
Planned (sponsor's estimate)
Start
Apr 14, 2026
Primary completion
Dec 2027
Study completion Jan 2028
Sponsor
- Lead sponsor
- Ambros Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Oct 7, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Phase 3 Trial of AMBTX-01 (neridronate) for Complex Regional Pain Syndrome Type 1
Conditions
- Complex Regional Pain Syndrome Type I
Interventions
NeridronateDrug
neridronate 100 mg, given as a 2-hour infusion on Days 1, 4, 7, and 10.
PlaceboDrug
placebo comparator
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in pain intensity from baseline to Week 12.Time frame: Week 12
Locations
36 sites in 1 country. Site status is shown where the registry gives one.
Ambros Clinical Trial Site
Phoenix, Arizona · Recruiting
Ambros Clinical Trial Site
Tucson, Arizona · Recruiting
Ambros Clinical Trial Site
Little Rock, Arkansas · Recruiting
Ambros Clinical Trial Site
La Jolla, California · Recruiting
Ambros Clinical Trial Site
Napa, California · Recruiting
Ambros Clinical Trial Site
Pasadena, California · Recruiting
Ambros Clinical Trial Site
Santa Monica, California · Recruiting
Ambros Clinical Trial Site
Tustin, California · Recruiting
Ambros Clinical Trial Site
Washington D.C., District of Columbia · Recruiting
Ambros Clinical Trial Site
Brandon, Florida · Recruiting
Ambros Clinical Trial Site
Daytona Beach, Florida · Recruiting
Ambros Clinical Trial Site
Pembroke Pines, Florida · Recruiting
Ambros Clinical Trial Site
Lawrenceville, Georgia · Recruiting
Ambros Clinical Trial Site
Newnan, Georgia · Recruiting
Ambros Clinical Trial Site
Chicago, Illinois · Recruiting
Ambros Clinical Trial Site
Orland Park, Illinois · Recruiting
Ambros Clinical Trial Site
Overland Park, Kansas · Recruiting
Ambros Clinical Trial Site
Dearborn, Michigan · Recruiting
Ambros Clinical Trial Site
Creve Coeur, Missouri · Recruiting
Ambros Clinical Trial Site
Reno, Nevada · Recruiting
Ambros Clinical Trial Site
Shrewsbury, New Jersey · Recruiting
Ambros Clinical Trial Site
Smithtown, New York · Recruiting
Ambros Clinical Trial Site
Charlotte, North Carolina · Recruiting
Ambros Clinical Trial Site
Wilmington, North Carolina · Recruiting
Ambros Clinical Trial Site
Winston-Salem, North Carolina · Recruiting
Ambros Clinical Trial Site
Cleveland, Ohio · Recruiting
Ambros Clinical Trial Site
Dayton, Ohio · Recruiting
Ambros Clinical Trial Site
Fort Worth, Texas · Recruiting
Ambros Clinical Trial Site
Houston, Texas · Recruiting
Ambros Clinical Trial Site
Lubbock, Texas · Recruiting
Ambros Clinical Trial Site
Mesquite, Texas · Recruiting
Ambros Clinical Trial Site
Mesquite, Texas · Recruiting
Ambros Clinical Trial Site
San Antonio, Texas · Recruiting
Ambros Clinical Trial Site
Charlottesville, Virginia · Recruiting
Ambros Clinical Trial Site
Richmond, Virginia · Recruiting
Ambros Clinical Trial Site
Seattle, Washington · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.